Cargando…

Calenduloside E Ameliorates Myocardial Ischemia-Reperfusion Injury through Regulation of AMPK and Mitochondrial OPA1

Calenduloside E (CE) is a natural triterpenoid saponin isolated from Aralia elata (Miq.) Seem., a well-known traditional Chinese medicine. Our previous studies have shown that CE exerts cardiovascular protective effects both in vivo and in vitro. However, its role in myocardial ischemia/reperfusion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Min, Wang, Rui-ying, Zhou, Jia-hui, Xie, Xue-heng, Sun, Gui-bo, Sun, Xiao-bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479459/ https://www.ncbi.nlm.nih.gov/pubmed/32934760 http://dx.doi.org/10.1155/2020/2415269

Ejemplares similares

Calenduloside E alleviates cerebral ischemia/reperfusion injury by preserving mitochondrial function
por: Li, Jianxiong, et al.
Publicado: (2022)

The clickable activity-based probe of anti-apoptotic calenduloside E
por: Tian, Yu, et al.
Publicado: (2019)

Calenduloside E suppresses calcium overload by promoting the interaction between L-type calcium channels and Bcl2-associated athanogene 3 to alleviate myocardial ischemia/reperfusion injury
por: Wang, Ruiying, et al.
Publicado: (2020)

Targets Fishing and Identification of Calenduloside E as Hsp90AB1: Design, Synthesis, and Evaluation of Clickable Activity-Based Probe
por: Wang, Shan, et al.
Publicado: (2018)

Empagliflozin improves renal ischemia–reperfusion injury by reducing inflammation and enhancing mitochondrial fusion through AMPK–OPA1 pathway promotion
por: Yang, Wenbo, et al.
Publicado: (2023)

APPL1 ameliorates myocardial ischemia-reperfusion injury by regulating the AMPK signaling pathway
por: Cen, Yunguang, et al.
Publicado: (2022)

Calenduloside E Analogues Protecting H9c2 Cardiomyocytes Against H(2)O(2)-Induced Apoptosis: Design, Synthesis and Biological Evaluation
por: Tian, Yu, et al.
Publicado: (2017)

Blockage of Fibronectin 1 Ameliorates Myocardial Ischemia/Reperfusion Injury in Association with Activation of AMP-LKB1-AMPK Signaling Pathway
por: Zhang, Yun-Long, et al.
Publicado: (2022)

Exogenous NADPH ameliorates myocardial ischemia–reperfusion injury in rats through activating AMPK/mTOR pathway
por: Zhu, Jiang, et al.
Publicado: (2019)

Rhynchophylline ameliorates myocardial ischemia/reperfusion injury through the modulation of mitochondrial mechanisms to mediate myocardial apoptosis
por: Qin, Qiao-Ji, et al.
Publicado: (2019)

Ischemia-induced cleavage of OPA1 at S1 site aggravates mitochondrial fragmentation and reperfusion injury in neurons
por: Li, Xiang, et al.
Publicado: (2022)

MCU Up‐regulation contributes to myocardial ischemia‐reperfusion Injury through calpain/OPA‐1–mediated mitochondrial fusion/mitophagy Inhibition
por: Guan, Lichun, et al.
Publicado: (2019)

AMPK Activation Alleviates Myocardial Ischemia-Reperfusion Injury by Regulating Drp1-Mediated Mitochondrial Dynamics
por: Du, Jingxia, et al.
Publicado: (2022)

Recombinant Adiponectin Ameliorates Liver Ischemia Reperfusion Injury via Activating the AMPK/eNOS Pathway
por: Zhang, Chuanzhao, et al.
Publicado: (2013)

Roflumilast reduces myocardial ischemia reperfusion injury in vivo and in vitro by activating the AMPK signaling pathway
por: Liao, Bo, et al.
Publicado: (2023)

Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1(+/-) Mouse Model
por: Le Page, Sophie, et al.
Publicado: (2016)

Melatonin ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1α-SIRT3 signaling
por: Yu, Liming, et al.
Publicado: (2017)

Muscone ameliorates myocardial ischemia‒reperfusion injury by promoting myocardial glycolysis
por: Gu, Xin, et al.
Publicado: (2023)

Ursolic Acid Ameliorates Myocardial Ischaemia/Reperfusion Injury by Improving Mitochondrial Function via Immunoproteasome-PP2A-AMPK Signalling
por: Xu, Luo-Luo, et al.
Publicado: (2023)

Irisin Attenuates Myocardial Ischemia/Reperfusion Injury and Improves Mitochondrial Function Through AMPK Pathway in Diabetic Mice
por: Xin, Chao, et al.
Publicado: (2020)

Amelioration of myocardial ischemia/reperfusion injury in diabetes: A narrative review of the mechanisms and clinical applications of dexmedetomidine
por: Sun, Meng, et al.
Publicado: (2022)

Melatonin improves mitochondrial biogenesis through the AMPK/PGC1α pathway to attenuate ischemia/reperfusion-induced myocardial damage
por: Qi, Xueyan, et al.
Publicado: (2020)

Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis
por: Ye, Jingxue, et al.
Publicado: (2021)

Sigma-1 Receptor Stimulation with PRE-084 Ameliorates Myocardial Ischemia-Reperfusion Injury in Rats
por: Gao, Qi-Jun, et al.
Publicado: (2018)

Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway
por: Ma, Chongyang, et al.
Publicado: (2019)

L‐Arginine‐Loaded Gold Nanocages Ameliorate Myocardial Ischemia/Reperfusion Injury by Promoting Nitric Oxide Production and Maintaining Mitochondrial Function
por: Wang, Zekun, et al.
Publicado: (2023)

Antiapoptotic Effect of Simvastatin Ameliorates Myocardial Ischemia/Reperfusion Injury
por: Hadi, Najah R., et al.
Publicado: (2013)

Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway
por: Yang, Ke, et al.
Publicado: (2023)

miR-451 on Myocardial Ischemia-Reperfusion in Rats by Regulating AMPK Signaling Pathway
por: Guo, Yulin, et al.
Publicado: (2021)

Role of Phosphorylated AMP-Activated Protein Kinase (AMPK) in Myocardial Insulin Resistance After Myocardial Ischemia-Reperfusion During Cardiopulmonary Bypass Surgery in Dogs
por: Zhang, Deng-Shen, et al.
Publicado: (2019)

Alda-1 treatment promotes the therapeutic effect of mitochondrial transplantation for myocardial ischemia-reperfusion injury()
por: Sun, Xiaolei, et al.
Publicado: (2021)

Diallyl trisulfide improves spinal cord ischemia–reperfusion injury damage by activating AMPK to stabilize mitochondrial function
por: Sun, Yang, et al.
Publicado: (2023)

Effects and Mechanisms of Chinese Herbal Medicine in Ameliorating Myocardial Ischemia-Reperfusion Injury
por: Liu, Qing, et al.
Publicado: (2013)

Activation of Nrf2 by Lithospermic Acid Ameliorates Myocardial Ischemia and Reperfusion Injury by Promoting Phosphorylation of AMP-Activated Protein Kinase α (AMPKα)
por: Zhang, Min, et al.
Publicado: (2021)

Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models
por: Civiletto, Gabriele, et al.
Publicado: (2015)

Recombinant Klotho Protein Ameliorates Myocardial Ischemia/Reperfusion Injury by Attenuating Sterile Inflammation
por: Myung, Jinwoo, et al.
Publicado: (2022)

Protective role of STVNa in myocardial ischemia reperfusion injury by inhibiting mitochondrial fission
por: Sun, Xiaoou, et al.
Publicado: (2017)

AMPK/SIRT1 Pathway is Involved in Arctigenin-Mediated Protective Effects Against Myocardial Ischemia-Reperfusion Injury
por: Liu, Cheng-Yin, et al.
Publicado: (2021)

Association Between L-OPA1 Cleavage and Cardiac Dysfunction During Ischemia-Reperfusion Injury in Rats
por: Rodríguez-Graciani, Keishla M., et al.
Publicado: (2020)

Role of AMPK in Myocardial Ischemia-Reperfusion Injury-Induced Cell Death in the Presence and Absence of Diabetes
por: Kandula, Nirupama, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0c4lqmrl9uuq5g0fners34d3mv